Instylla HES Hypervascular Tumor Pivotal Study

Clinical trial NCT04523350 · COMPLETED

Trial details

NCT number: NCT04523350
Sponsor: Instylla, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hypervascular Tumors

Start date: 2021-03-05
Primary completion: 2024-05-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.